| Date Filed | Type | Description |
| 10/04/2023 |
4
| Sherman Matthew L (EVP & Chief Medical Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 2,942 shares
@ $12.68, valued at
$37.3k
|
|
| 06/12/2023 |
4
| Friedman Franklin Stuart (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Bought 10,000 shares
@ $13.8828, valued at
$138.8k
|
|
| 03/23/2023 |
4
| Hoerter Steven L. (President and CEO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 7,500 shares
@ $15.5709, valued at
$116.8k
|
|
| 03/01/2023 |
4
| Brightstar Associates LLC (10% Owner) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Exercised (in-or-at-the-money) 2,427,693 warrants
@ $0.01, valued at
$24.3k
|
|
| 01/24/2023 |
4
| Brightstar Associates LLC (10% Owner) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Bought 1,666,666 shares
@ $18, valued at
$30M
|
|
| 01/19/2023 |
4
| Friedman Franklin Stuart (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 3,269 options to buy
@ $21.27, valued at
$69.5k
|
|
| 01/19/2023 |
4
| Flynn Daniel Lee (Chief Scientific Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 2,403 shares
@ $21.2413, valued at
$51k
|
|
| 01/19/2023 |
4
| Pitman Jama (See Remarks) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 1,603 shares
@ $21.2413, valued at
$34k
|
|
| 01/19/2023 |
4
| Sherman Matthew L (EVP & Chief Medical Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 2,403 shares
@ $21.2413, valued at
$51k
|
|
| 01/19/2023 |
4
| Allen Patricia L (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 3,269 options to buy
@ $21.27, valued at
$69.5k
|
|
| 01/19/2023 |
4
| Martin Daniel C. (Chief Commercial Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 1,603 shares
@ $21.2413, valued at
$34k
|
|
| 01/19/2023 |
4
| Kelly Thomas Patrick (CFO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 2,403 shares
@ $21.2413, valued at
$51k
|
|
| 01/19/2023 |
4
| Walsh Dennis Leo (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 3,269 options to buy
@ $21.27, valued at
$69.5k
|
|
| 01/19/2023 |
4
| Squarer Ron (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 3,269 options to buy
@ $21.27, valued at
$69.5k
|
|
| 01/19/2023 |
4
| Kelley Susan L. (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 3,269 options to buy
@ $21.27, valued at
$69.5k
|
|
| 10/05/2022 |
4
| Sherman Matthew L (EVP & Chief Medical Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 2,587 shares
@ $18.73, valued at
$48.5k
|
|
| 06/24/2022 |
4
| Walsh Dennis Leo (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 18,500 options to buy
@ $13.98, valued at
$258.6k
|
|
| 06/24/2022 |
4
| Bristol James Arthur (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 18,500 options to buy
@ $13.98, valued at
$258.6k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Martin John Richard (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 18,500 options to buy
@ $13.98, valued at
$258.6k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Benz Edward J. JR (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 18,500 options to buy
@ $13.98, valued at
$258.6k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Pitman Jama (See Remarks) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 1,298 shares
@ $10.75, valued at
$14k
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Kelly Thomas Patrick (CFO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 1,768 shares
@ $10.75, valued at
$19k
|
|
| 06/21/2022 |
4
| Flynn Daniel Lee (Chief Scientific Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 1,768 shares
@ $10.75, valued at
$19k
|
|
| 04/29/2022 |
4
| Brightstar Associates LLC (10% Owner) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Bought 1,478,978 shares
@ $10, valued at
$14.8M
Bought 3,389,830 warrants
@ $0.01, valued at
$33.9k
|
|
| 03/23/2022 |
4
| Hoerter Steven L. (President and CEO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 3,150 shares
@ $9.11, valued at
$28.7k
|
|
| 02/18/2022 |
4
| Flynn Daniel Lee (Chief Scientific Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 1,366 shares
@ $9.05, valued at
$12.4k
|
|
| 02/18/2022 |
4
| Martin Daniel C. (Chief Commercial Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 1,146 shares
@ $9.05, valued at
$10.4k
|
|
| 02/18/2022 |
4
| Sherman Matthew L (EVP & Chief Medical Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 984 shares
@ $9.05, valued at
$8.9k
|
|
|